Economic and Political Weekly: “The Glivec Precedent”
I write to share news about a set of articles that critically evaluate the recent Supreme Court of India’s decision on the patentability of Glivec – the Novartis anti-cancer drug. The ruling that finds Glivec foul of the standards under…